Alto Neuroscience (ANRO) Invested Capital (2024 - 2026)

Alto Neuroscience (ANRO) has 3 years of Invested Capital data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (down 53.46% YoY), and the FY2025 full-year result was $585000.0, changed N/A from the prior year.
• Invested Capital grew to $2.1 million in Q1 2026, from $585000.0 in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $3.5 million in Q3 2024 to a low of $585000.0 in Q4 2025.
• A 3-year average of $1.9 million and a median of $2.1 million in 2026 frame the typical range for Invested Capital.